These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22078674)

  • 1. Reporting quality of life in clinical trials: a CONSORT extension.
    Calvert M; Blazeby J; Revicki D; Moher D; Brundage M
    Lancet; 2011 Nov; 378(9804):1684-5. PubMed ID: 22078674
    [No Abstract]   [Full Text] [Related]  

  • 2. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials].
    Moher D; Schulz KF; Altman DG;
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):658-61. PubMed ID: 16089150
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the quality of reporting alcohol outcome studies: effects of the CONSORT statement.
    Ladd BO; McCrady BS; Manuel JK; Campbell W
    Addict Behav; 2010 Jul; 35(7):660-6. PubMed ID: 20207490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].
    Moher D; Schulz KF; Altman DG;
    Schmerz; 2005 Apr; 19(2):156-62. PubMed ID: 15700113
    [No Abstract]   [Full Text] [Related]  

  • 7. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Ann Intern Med; 2010 Jun; 152(11):726-32. PubMed ID: 20335313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version).
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):W7-W20. PubMed ID: 28654988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CONSORT 2010 statement: extension to randomised crossover trials.
    Dwan K; Li T; Altman DG; Elbourne D
    BMJ; 2019 Jul; 366():l4378. PubMed ID: 31366597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond.
    Moher D; Altman DG; Schulz KF; Elbourne DR
    CMAJ; 2004 Aug; 171(4):349-50. PubMed ID: 15313995
    [No Abstract]   [Full Text] [Related]  

  • 11. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Bian ZX; Shang HC
    Ann Intern Med; 2011 Feb; 154(4):290-1; author reply 291-2. PubMed ID: 21320945
    [No Abstract]   [Full Text] [Related]  

  • 12. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Obstet Gynecol; 2010 May; 115(5):1063-1070. PubMed ID: 20410783
    [No Abstract]   [Full Text] [Related]  

  • 13. Relevance of CONSORT reporting criteria for research on eHealth interventions.
    Baker TB; Gustafson DH; Shaw B; Hawkins R; Pingree S; Roberts L; Strecher V
    Patient Educ Couns; 2010 Dec; 81 Suppl():S77-86. PubMed ID: 20843621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Better reporting of harms in randomized trials: an extension of the CONSORT statement].
    Gøtzsche PC;
    Ugeskr Laeger; 2005 Apr; 167(14):1520-2. PubMed ID: 15887748
    [No Abstract]   [Full Text] [Related]  

  • 16. The CONSORT Framework.
    Merkow RP; Kaji AH; Itani KMF
    JAMA Surg; 2021 Sep; 156(9):877-878. PubMed ID: 33825818
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the reporting quality of randomised controlled trials in surgery.
    Carney S
    Int J Surg; 2007 Dec; 5(6):376. PubMed ID: 18063433
    [No Abstract]   [Full Text] [Related]  

  • 18. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    J Clin Epidemiol; 2010 Aug; 63(8):834-40. PubMed ID: 20346629
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the quality of reports of randomised controlled trials: the CONSORT statement.
    Otwombe KN; Ogutu B
    East Afr Med J; 2002 Jul; 79(7):394-6. PubMed ID: 12638837
    [No Abstract]   [Full Text] [Related]  

  • 20. Reporting of randomised controlled trials.
    Counsell C
    Lancet; 2001 Aug; 358(9281):585. PubMed ID: 11526927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.